A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
A study to evaluate the efficacy and safety of dasotraline in children 6 to 12 years of age with Attention-Deficit Hyperactivity Disorder (ADHD) in a simulated classroom setting.
Epistemonikos ID: 44b0ab8e5fbca4dd7759dc5d59cdb73a02ac0292
First added on: May 21, 2024